Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Methodology|Interests|Funding|Corrections
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Defined term · Evidence assessment

Publication bias

The risk that the studies available to a review are not a representative sample of the studies conducted, most often because studies with unfavourable results were not published. Suspected where the…

Document identifier
CEI-GT-014
Series
Defined term
Version
1.0
Published
30 Jul 2026
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Publication bias

§1.1Also known as

Small-study effects

§1.2Category

Evidence assessment — Terms describing how the Institute judges and reports the strength of evidence.

§1.3Related terms

  • Funnel plot — A scatter of effect estimate against study precision, inspected for asymmetry as an indication of small-study effects. Uninformative below approximately ten contributing…
  • Selective outcome reporting — The reporting of a subset of measured outcomes chosen after the results were known. Detected by comparing the published report with the registered protocol, which the…
Compound Evidence Institute · CEI-GT-014 · https://compoundevidence.com/glossary/publication-bias/ · retrieved 30 July 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.